
Richard Kelly – Is it possible to discontinue anticoagulation in patients with PNH?
VJHemOnc shared on X:
“Is it possible to discontinue anticoagulation in patients with PNH?
Dr Richard Kelly commented on this in a recent interview at IPIG2025, which you can watch.”
Watch the full interview on VJHemOnc to explore whether anticoagulation withdrawal is feasible—and for whom
Can anticoagulation safely be discontinued in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)? This pressing clinical question was recently addressed by Dr. Richard Kelly during an interview at the International PNH Interest Group Congress (IPIG 2025). As treatment paradigms evolve with the advent of complement inhibitors, the traditional rationale for long-term anticoagulation in PNH patients is being actively re-evaluated”.
Dr. Kelly shares insights into emerging data, individualized risk stratification, and the potential for safe de-escalation of anticoagulant therapy in select patients with controlled hemolysis and no history of thrombosis.
You can read a wide variety of new posts in Hemostasis Today.
-
Jun 12, 2025, 10:34Apply Now: HTRS Funding Opportunities for Aspiring Hemostasis Researchers
-
Jun 12, 2025, 10:33Review of Factor IX Replacement Therapy in Hemophilia B with CSL Behring on June 22
-
Jun 12, 2025, 10:30Dr. Laura Girardi Awarded 2025 Thrombosis Canada – CanVECTOR Research Fellowship
-
Jun 12, 2025, 10:21Elevate Your Career: American Society of Hematology Clinical Research Training Institute in the Mediterranean, Middle East, and North Africa
-
Jun 12, 2025, 07:45Richard Kelly - Is it possible to discontinue anticoagulation in patients with PNH?
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Jun 7, 2025, 08:46David Smadja: A Major Step Forward in The Fight Against Cancer-Related Thrombosis
-
Jun 6, 2025, 15:52Long-term Efficacy and Safety of Mitapivat in Non-Transfusion-Dependent α- or β-thalassaemia - British Journal of Haematology
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation